Literature DB >> 21855986

Morpho-functional studies regarding the fertility prognosis of mares suffering from equine endometrosis.

J Lehmann1, C Ellenberger, C Hoffmann, F W Bazer, J Klug, W R Allen, H Sieme, H-A Schoon.   

Abstract

The aim of the present study was to characterize the morpho-functional features of endometrosis in barren and foaling mares, using both conventional histopathological and immunohistochemical methods. Endometrial biopsy samples were collected during the physiological breeding season from 159 estrous, clinically healthy mares (mean age 12 years), and the quality and degree of endometrosis was histomorphologically defined. The mares were bred and those that foaled were put in the foaling group whereas those that did not foal were placed in the barren group. Foaling mares were then compared with barren mares. Sixty-four percent (101/159) of uterine samples showed varying degrees of endometrosis and were used for this study. The sample population consisted of 51 barren and 50 foaling mares suffering from endometrosis. Expression of steroid hormone receptors (estrogen receptor, progesterone receptor) and endometrial protein secretion patterns (uteroglobin [UG], uterocalin [UC], calbindin(D9k) [CAL], uteroferrin [UF]) was evaluated by immunohistochemistry (barren mares N = 51, foaling mares N = 31). In comparison with unaffected glands, fibrotic glands generally showed a cycle-asynchronous, partially patchy protein expression pattern which is interpreted as a sign of endometrial maldifferentiation within fibrotic areas. In barren mares (N = 51) more than half of biopsy samples (27/51) showed a destructive mostly moderate (20/27) type of endometrosis. In affected glands, staining for UG (17/21) was decreased (P < 0.001). Foaling mares (N = 50) frequently showed a mild, nondestructive endometrosis (35/50). Compared with barren mares, foaling mares had statistically (P < 0.05) more often a cycle-synchronous or increased UG expression pattern within fibrotic glands. Obvious deviations of either UG or UC rarely occurred. Within fibrotic foci, UF often demonstrated a cycle-synchronous or more intense expression pattern in both foaling (28/31) and barren mares (41/51), compared with healthy glands. Mares of both groups showed a cycle-asynchronous staining for estrogen receptor and progesterone receptor in the stromal cells in areas of periglandular fibrosis and the glandular epithelia. These findings indicate that affected areas become independent of the uterine control mechanisms and exhibit specific differentiation dynamics. Immunohistochemical investigations showed that the secretory patterns differ between barren and foaling mares. The findings in this study should be considered as a useful addition to the "classical" Kenney categorization.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855986     DOI: 10.1016/j.theriogenology.2011.06.001

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  10 in total

Review 1.  IIB or not IIB, part 1: retrospective evaluation of Kenney-Doig categorization of equine endometrial biopsies at a veterinary diagnostic laboratory and comparison with published reports.

Authors:  Jane Westendorf; Bruce Wobeser; Tasha Epp
Journal:  J Vet Diagn Invest       Date:  2021-11-28       Impact factor: 1.279

2.  IIB or not IIB, part 2: assessing inter-rater and intra-rater repeatability of the Kenney-Doig scale in equine endometrial biopsy evaluation.

Authors:  Jane Westendorf; Bruce Wobeser; Tasha Epp
Journal:  J Vet Diagn Invest       Date:  2021-12-29       Impact factor: 1.279

3.  Molecular Mechanism of Equine Endometrosis: The NF-κB-Dependent Pathway Underlies the Ovarian Steroid Receptors' Dysfunction.

Authors:  Tomasz Jasiński; Łukasz Zdrojkowski; Graça Ferreira-Dias; Ewa Kautz; Edyta Juszczuk-Kubiak; Małgorzata Domino
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

4.  Changes in expression pattern of selected endometrial proteins following mesenchymal stem cells infusion in mares with endometrosis.

Authors:  Lisley I Mambelli; Rodrigo C Mattos; Gustavo H Z Winter; Dener S Madeiro; Bruna P Morais; Eduardo Malschitzky; Maria Angélica Miglino; Alexandre Kerkis; Irina Kerkis
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

5.  Matrix metallopeptidase expression and modulation by transforming growth factor-β1 in equine endometrosis.

Authors:  Anna Szóstek-Mioduchowska; Mariola Słowińska; Joanna Pacewicz; Dariusz J Skarzynski; Kiyoshi Okuda
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

6.  Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare.

Authors:  Anna Szóstek-Mioduchowska; Natalia Leciejewska; Beata Zelmańska; Joanna Staszkiewicz-Chodor; Graça Ferreira-Dias; Dariusz Skarzynski
Journal:  BMC Vet Res       Date:  2020-09-17       Impact factor: 2.741

Review 7.  Adipose-Derived Stromal/Stem Cells from Large Animal Models: from Basic to Applied Science.

Authors:  Joanna Bukowska; Anna Zuzanna Szóstek-Mioduchowska; Marta Kopcewicz; Katarzyna Walendzik; Sylwia Machcińska; Barbara Gawrońska-Kozak
Journal:  Stem Cell Rev Rep       Date:  2020-10-06       Impact factor: 5.739

8.  Histopathological characteristics of endometrosis in thoroughbred mares in Japan: results from 50 necropsy cases.

Authors:  Michiko Hanada; Yousuke Maeda; Masa-Aki Oikawa
Journal:  J Equine Sci       Date:  2014-06-25

Review 9.  The Healthy and Diseased Equine Endometrium: A Review of Morphological Features and Molecular Analyses.

Authors:  Sandra Schöniger; Heinz-Adolf Schoon
Journal:  Animals (Basel)       Date:  2020-04-05       Impact factor: 2.752

10.  Different expression of Defensin-B gene in the endometrium of mares of different age during the breeding season.

Authors:  M Crociati; S Capomaccio; M T Mandara; G Stradaioli; L Sylla; M Monaci; K Cappelli
Journal:  BMC Vet Res       Date:  2019-12-21       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.